More than one-quarter of the world’s population were constantly getting affected with the one of the world’s oldest and deadliest disease named Tuberculosis (TB). In spite of 6-9 months antibiotic therapy, it’s very difficult to treat tuberculosis. That’s why researchers throughout the world were trying to find the faster ways of cure.
Previous research on color blindness correction was conducted using gene therapy, while EnChroma developed sunglasses which could correct the issue. But they were bulky and expensive, and could not be used with regular corrective lenses.
In the pilot phase, individual grants would be provided which would range from $250,000 to $2 million over two years. An additional $10 million may be provided if project is promising in animal studies but that money won’t be the part of this funding round
The company announced that the innovative product, whose technological details are not known yet, is undergoing clinical trials in five cities across the world. The patent-pending invention is based on open standards software and cloud-based analytics. The system gives users real-time notifications and cloud-based AI solutions.
Rabies takes nearly 60,000 lives each year; it is deadly if not treated early. Regions like Africa and Asia are at higher risk. LN34 is believed to make screening faster and better test to avoid the weeks-long series of shots now given to prevent the disease for the people exposed to potentially rabid. The test, done on suspect animals, can be run on platforms which are already used to screen for the flu, tuberculosis, and HIV.
A mobile health app developed by Medici is used by Kim who has stated that the technology helps him make the right connect with patients. He can log on to his smartphone or iPad when at home and make a HIPAA-compliant connection with concerned persons impacted by crisis or who would turn to medication.
A research team led by Yokohama City University and Toyama Chemical Co Ltd in Japan has developed a small compound named edonerpic maleate that showed enhanced recovery of motor function after brain damage in animal trials.
iPhone maker Apple is all set to disrupt the conventionalities of medical data storage methodologies. The company has announced the development of a new health record app, a new standard that has been adopted by many big companies for transferring records across scattered systems. Apple is all set to break the traditional systems of several silos in which medical data is stored.
FMCG major Marico has announced that it will be investing in Revolutionary Fitness, owner of health and fitness app Revofit. The company stated that it will acquire around 22.5 percent stake in the health startup.
EIP Pharma raised $20.5 million series B funding to support Neflamapimod, the phase 2b program of its Alzheimer treatment. The funding is also to build the team and to support other research studies related to central nervous system disorders.
your submission has already been received.
Please enter a valid Email address！
The most relevant industry news & insight will be sent to you every two weeks.